<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01208311</url>
  </required_header>
  <id_info>
    <org_study_id>4539</org_study_id>
    <nct_id>NCT01208311</nct_id>
  </id_info>
  <brief_title>Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound</brief_title>
  <official_title>Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the amount of fibrosis in the liver of hepatitis C
      patients with advanced fibrosis, using endoscopic ultrasound.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Transabdominal ultrasound cannot be used to quantitate fibrosis in patients with
      cirrhosis due to variability in the abdominal wall thickness and composition. This
      variability can be eliminated by using endoscopic ultrasound.

      Aim: To determine the amount of fibrosis in the liver of hepatitis C patients with advanced
      fibrosis, using endoscopic ultrasound.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Luminosity on ultrasound</measure>
    <time_frame>Once at the time of the endoscopic ultrasound</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">7</enrollment>
  <condition>Alcoholism</condition>
  <condition>Cirrhosis</condition>
  <condition>Hepatitis c</condition>
  <arm_group>
    <arm_group_label>Patients with Hepatitis C Cirrhosis</arm_group_label>
    <description>Patients with Hepatitis C Cirrhosis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Collect endoscopic ultrasound images form normal subjects, alcoholic liver patients and
        patients with hepatitis C Cirrhosis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hepatic cirrhosis and hepatitis C and undergoing endoscopy

          -  Alcoholic liver and undergoing endoscopy

          -  Normal liver undergoing endoscopy

        Exclusion Criteria:

          -  pregnancy

          -  Children
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Larry S Miller, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Feinstein Institute for Medical Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>LIJ Medical Center- NSLIJ Health System</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brown JJ, Naylor MJ, Yagan N. Imaging of hepatic cirrhosis. Radiology. 1997 Jan;202(1):1-16. Review.</citation>
    <PMID>8988182</PMID>
  </reference>
  <reference>
    <citation>Mergo PJ, Ros PR. Imaging of diffuse liver disease. Radiol Clin North Am. 1998 Mar;36(2):365-75. Review.</citation>
    <PMID>9520988</PMID>
  </reference>
  <reference>
    <citation>Taylor HM, Ros PR. Hepatic imaging. An overview. Radiol Clin North Am. 1998 Mar;36(2):237-45. Review.</citation>
    <PMID>9520979</PMID>
  </reference>
  <reference>
    <citation>Zwiebel WJ. Sonographic diagnosis of diffuse liver disease. Semin Ultrasound CT MR. 1995 Feb;16(1):8-15. Review.</citation>
    <PMID>7718284</PMID>
  </reference>
  <reference>
    <citation>Aubé C, Oberti F, Korali N, Namour MA, Loisel D, Tanguy JY, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Rifflet H, Maïga MY, Penneau-Fontbonne D, Caron C, Calès P. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol. 1999 Mar;30(3):472-8.</citation>
    <PMID>10190731</PMID>
  </reference>
  <reference>
    <citation>Harbin WP, Robert NJ, Ferrucci JT Jr. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology. 1980 May;135(2):273-83.</citation>
    <PMID>7367613</PMID>
  </reference>
  <reference>
    <citation>Hirata M, Akbar SM, Horiike N, Onji M. Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virus. Eur J Clin Invest. 2001 Jun;31(6):528-35.</citation>
    <PMID>11422403</PMID>
  </reference>
  <reference>
    <citation>Hultcrantz R, Gabrielsson N. Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med. 1993 Jan;233(1):7-12.</citation>
    <PMID>8429291</PMID>
  </reference>
  <reference>
    <citation>Zheng RQ, Wang QH, Lu MD, Xie SB, Ren J, Su ZZ, Cai YK, Yao JL. Liver fibrosis in chronic viral hepatitis: an ultrasonographic study. World J Gastroenterol. 2003 Nov;9(11):2484-9.</citation>
    <PMID>14606081</PMID>
  </reference>
  <results_reference>
    <citation>Andanappa HK, Dai Q, Korimilli A, Panganamamula K, Friedenberg F, Miller L. Acoustic liver biopsy using endoscopic ultrasound. Dig Dis Sci. 2008 Apr;53(4):1078-83. doi: 10.1007/s10620-008-0211-4. Epub 2008 Feb 13.</citation>
    <PMID>18270828</PMID>
  </results_reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2010</study_first_submitted>
  <study_first_submitted_qc>September 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2010</study_first_posted>
  <last_update_submitted>December 28, 2016</last_update_submitted>
  <last_update_submitted_qc>December 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwell Health</investigator_affiliation>
    <investigator_full_name>Larry Miller</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Alcoholic cirrhosis</keyword>
  <keyword>hepatitis c cirrhosis</keyword>
  <keyword>cirrhosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

